Skip to content

EPA and DHA supplements changed blood fat patterns in an exploratory trial

An analysis of trial samples found changes in circulating fatty acids and related compounds. It did not establish that participants experienced less inflammation or better health.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Supplementation changed where EPA and DHA appeared among fats circulating in the blood, and increased related compounds called oxylipins compared with corn oil. These results describe biochemical changes. They do not establish that symptoms improved or disease risk fell, and the authors call for further research connecting these changes with markers of inflammation.

Keep in mind

This abstract-based explanation covers an exploratory analysis using available samples, mostly from women. The abstract reports biochemical outcomes and does not establish clinical benefit or explain how representative the available samples were.

THE RESULT, WITH CONTEXT

What researchers found

Significantly higher

Plasma EPA+DHA and derived oxylipin levels

EPA+DHA supplementation versus corn oil after 12 weeks, across plasma lipid pools; the abstract provides no numerical effect size.

J Nutr, 2026 · Original source ↓

Where the fats went

Researchers measured fatty acids in several categories of blood lipids. EPA increased in every category named in the abstract, while DHA increased in several. This describes the distribution of supplemental fats within blood samples.

What the compounds show

Oxylipins described as anti-inflammatory generally rose, while those described as proinflammatory generally fell relative to baseline. These labels describe the compounds measured; they do not show that inflammation-related illness improved in participants.

CHECK THE ORIGINAL

The original publication

Effects of EPA+DHA and Corn Oil Supplementation on PUFA Concentrations across Plasma Lipid Pools and on Downstream Oxylipins: Exploratory Results from a Randomized Controlled Trial in Healthy Humans.

Balakrishnan N, Shaikh SR, Childs CE et al.
J Nutr · 2026

PubMed ID
41461265
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.